In the current study, we showed that among glycolytic enzymes LDHA protein levels show the highest correlation with glycolytic activity in AML cells, and that LDHA inhibition shows potent anti-leukemic effects in both AML cell lines and primary patient samples, while sparing non-malignant hematopoietic cells. This evidence concerns the gene LDHA and acute myeloid leukemia.